Hilke Vorwerk
University of Marburg
44 Papers
369 Citations
Hilke Vorwerk is an academic researcher from University of Marburg. The author has contributed to research in topics: Medicine & Radiation therapy. The author has an hindex of 19, co-authored 43 publications. Previous affiliations of Hilke Vorwerk include University of Göttingen.
Chat about Author
Papers
Radiotherapy of malignant gliomas: Comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique
TL;DR: RapidArc was faster than conventional IMRT and should be preferred if PTV coverage is adequate, and otherwise an intensity-modulated technique should be used.
124
Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of the clinical target volume. A comparison between gynaecologic and radiation oncologists.
Elisabeth Weiss,Susanne Richter,T. Krauss,Silke I Metzelthin,Andrea Hille,Olivier Pradier,Birgit Siekmeyer,Hilke Vorwerk,Clemens F. Hess +8 more
TL;DR: Although there was a good consistency in outlined anatomical structures, for the radiation therapy of carcinomas of the uterine cervix a large interobserver variability in CTV delineation concerning the magnitude and relative location of volumes was observed.
97
Testicular dose and hormonal changes after radiotherapy of rectal cancer
Robert Michael Hermann,Karsten Henkel,Hans Christiansen,Hilke Vorwerk,Andrea Hille,Clemens F. Hess,Heinz Schmidberger +6 more
TL;DR: No correlation could be found between changes of hormones and doses to the testis, probably due to the low number of evaluated patients, and larger studies are needed to establish the correlation between testicular radiation dose and hormonal changes in this group of patients.
95
Interfractional and intrafractional accuracy during radiotherapy of gynecologic carcinomas: a comprehensive evaluation using the ExacTrac system.
TL;DR: The analysis of registered body marker positions revealed a wide variation in respiratory frequencies, breathing amplitudes, and patient displacements with interfractional and intrafractional time trends.
60
Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
Hendrik A. Wolff,Tobias Overbeck,Ralph M.W. Roedel,Robert Michael Hermann,Markus K. A. Herrmann,Tereza Kertesz,Hilke Vorwerk,Andrea Hille,Christoph Matthias,Clemens F. Hess,Hans Christiansen +10 more
TL;DR: Chemoradiation with daily-low-dose-cisplatin to be feasible with advantage of low acute and chronic toxicity and should be evaluated in future clinical trials.